Confirm delete?

Bertin Bioreagent
logo
All categories
Contact Us
You are here :

Q-Plex™ Human Cytokine Panel 2 (4-plex)

  • Zoom
    Q-Plex™ Human Cytokine Panel 2 (4-plex)
  • Q-Plex™ Human Cytokine Panel 2 (4-plex)
Cat No: 31855
Assay Kits - More Assay Kits
Cayman

The Q-Plex™ Human Cytokine Panel 2 (4-plex) is a fully quantitative ELISA-based chemiluminescent assay allowing concurrent measurement of four biomarkers or analytes (IL-1α, IL-4, IL-6, TNFα). Using just 25 µl of sample per well, up to 80 samples can ...

More
: 1 ea

This product can only be bought through Cayman Chemical. Please contact us.

Territorial Availability: Available through Bertin Technologies only in France
Correlated keywords:
  • 112033 HU IL1? IL4 IL6 TNF ? 4plex Qplex
Product Overview:
The Q-Plex™ Human Cytokine Panel 2 (4-plex) is a fully quantitative ELISA-based chemiluminescent assay allowing concurrent measurement of four biomarkers or analytes (IL-1α, IL-4, IL-6, TNFα). Using just 25 µl of sample per well, up to 80 samples can be assayed for all four markers in the panel in 2.25 hours. Q-Plex Arrays provide scientists with an easy-to-use and cost-effective means of generating a cytokine profile for each sample. Q-Plex plates are built by absorbing four distinct capture antibodies in a defined array to the bottom of each well. Our high-quality reagents help ensure the accuracy of your results. See Item No. 28265 to view pricing and specifications for the Q-View™ Imager Pro or Item No. 28264 for the Q-View™ Imager LS. Species: Human Sample Type: Serum, EDTA/Heparin Plasma Volume Required per Well: 25 µl, minimum Assay Length: 2.25 hours Specificity: All analytes Assay Type: Planar Based Multiplexed ELISA Detection Method: Q-View™ Chemiluminescent Imaging System Item No. 28264 or Item No. 28265 Multiplex Format: 96-well solid plate [Quansys Catalog No. 112033HU]
Size 1 ea
Shipping wet ice
Custom Code 3822.19
UNSPSC code 41116104

Click here to ask for your quote and get 15% off Cayman's products.

 

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

Search